Home > > North America And Global Endoluminal Suturing Devices Market- Size, Share, Growth Rate, and Forecast
The North America Endoluminal Suturing Devices market was valued at $1,876.0 Million in 2024, and is projected to reach $3,620.8 Million by 2031 growing at a CAGR of 9.90% from 2025 to 2031. Gastrointestinal Surgery segment is expected to be the highest contributor to this market, with $614.4 Million in 2024, and is anticipated to reach $1,107.5 by 2031, registering a CAGR of 8.83%. Bariatric Surgery segment is anticipated to reach $1,031.4 Million by 2031 with the highest CAGR of 11.16%. Gastrointestinal Surgery and Bariatric Surgery segments collectively expected to account for about 59.0% share of the North America Endoluminal Suturing Devices market in 2024, with the former constituting around 32.8% share. Bariatric Surgery and Gastroesophageal Reflux Disease Surgery segments are expected to witness significant growth rates at a CAGR of 11.16% and 10.43% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 45.9% in the overall North America Endoluminal Suturing Devices market in 2024, and is anticipated to reach 48.8% by 2031.